Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
XOM Exxon Mobil Corp
CMI Cummins Inc
OILX UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN
RUN Sunrun Inc
BAC Bank of America Corp
HLT Hilton Worldwide Holdings Inc
MNMT Motivating Masses Inc
FTA.IV First Trust Large Cap Value Oppts Alpha
MSFT Microsoft Corp

Health Care : Biotechnology | Mid Cap GrowthCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD). It is focused on the development of its disease-modifying DMD drug candidates. It has received accelerated approval for its product, EXONDYS 51, indicated for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. EXONDYS 51 is studied in clinical trials under the name of eteplirsen. Its next generation phosphorodiamidate morpholino oligomer (PMO)-based compounds are synthetic compounds that bind to complementary sequences of RNA by standard Watson-Crick nucleobase pairing. Its PMO-based chemistries are peptide conjugated PMO (PPMO), PMO-X and PMOplus.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: Apple and Goldman's new credit card can't be used to buy cryptocurrencies

7:54 pm ET August 4, 2019 (MarketWatch)

By Mike Murphy

Apple Card could be launched later this month

Apple Inc. and Goldman Sachs Group Inc. will soon launch their new credit card, but are saying "no dice" for users who want to buy cryptocurrencies with it.

That's apparently just too big of a gamble.

"You may not use or permit your account to be used for ... cash advances or cash equivalents," reads the Apple Card Customer Agreement, which was posted Friday on Goldman's web site ( Goldman said it considers "cash advances or cash equivalents" to include cryptocurrency, peer-to-peer transfers, lottery tickets, gambling chips, race-track wagers, travelers checks, foreign currency and wire transfers.

While neither Apple (AAPL) nor Goldman (GS) immediately commented on the crypto ban, other banking companies, such as JPMorgan Chase Co. (JPM) and Citigroup Inc. (C) , have similar policies (, aimed at protecting users from accumulating massive debts as the result of the volatile price swings of bitcoin and other crpytos.

The Apple Card agreement also says users may not use accounts that are linked with an iPhone that has been subject to unauthorized modification, a process of disabling hardware of software controls known as "jailbreaking."

During Apple's quarterly earnings conference call ( week, Chief Executive Tim Cook said Apple plans to launch the card this month.

Apple shares are up 29% year to date, while Goldman Sachs is up 25%, compared to a 14% gain for the Dow Jones Industrial Average , of which both are components.

-Mike Murphy; 415-439-6400;

(END) Dow Jones Newswires

August 04, 2019 19:54 ET (23:54 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.